You must log in to view this page.

NRX Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: NRXP
Share price (6/30/26): $4.09
Market cap (6/30/26): $148 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Late quarterly filing notification for Q2 2025

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Anson Funds Management LP

Casper Joseph Michael

Casper Joseph Michael

Javitt Jonathan C

News Filter

Announces Pricing of Public Offering of Common Stock

Announces Proposed Public Offering of Common Stock

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Announces Path to New Drug Application With Real World Data and Broader Proposed Indication for NRX-100 (Ketamine) Following Type C FDA Meeting

Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission